{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:27:12Z","timestamp":1778405232576,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ebr.2025.100758","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:28:57Z","timestamp":1740702537000},"page":"100758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Major depression, anxiety disorder and suicidality in epilepsy: What should neurologists do?"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-8034","authenticated-orcid":false,"given":"Andres M.","family":"Kanner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebr.2025.100758_b0005","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100758_b0010","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders \u2013 Fifth Edition \u2013 Text Revision DSM-V-TR, 2022."},{"key":"10.1016\/j.ebr.2025.100758_b0015","first-page":"e112","article-title":"Psychiatric comorbidities in people with epilepsy","volume":"11","author":"Mula","year":"2021","journal-title":"Neurol: Clin Pract"},{"key":"10.1016\/j.ebr.2025.100758_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2022.898547","article-title":"Suicidality in patients with epilepsy: why should neurologists care?","volume":"16","author":"Kanner","year":"2022","journal-title":"Front Integr Neurosci"},{"key":"10.1016\/j.ebr.2025.100758_b0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(07)70175-8","article-title":"Epilepsy and risk of suicide: a population-based case\u2013control study","volume":"6","author":"Christensen","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebr.2025.100758_b0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/epi.13769","article-title":"Anxiety and depressive disorders in people with epilepsy: a meta-analysis","volume":"58","author":"Scott","year":"2017","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.ebr.2025.100758_b0035","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1212\/WNL.0000000000201671","article-title":"Mood and anxiety disorders and suicidality in patients with newly diagnosed focal epilepsy: an analysis of a complex comorbidity","volume":"100","author":"Kanner","year":"2023","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebr.2025.100758_b0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1528-1167.2012.03488.x","article-title":"Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events?","volume":"53","author":"Kanner","year":"2012","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.ebr.2025.100758_b0045","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/epi.13781","article-title":"Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE","volume":"58","author":"Nogueira","year":"2017","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ebr.2025.100758_b0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.yebeh.2003.07.009","article-title":"Epilepsy Impact Project Group. The influence of comorbid depression on quality of life for people with epilepsy","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"9905","key":"10.1016\/j.ebr.2025.100758_b0055","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(13)60899-5","article-title":"Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study","volume":"382","author":"Fazel","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebr.2025.100758_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1528-1157.1997.tb01102.x","article-title":"Patient-validated content of epilepsy-specific quality-of-life measurement","volume":"38","author":"Gilliam","year":"1997","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ebr.2025.100758_b0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamaneurol.2016.5042","article-title":"Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis","volume":"74","author":"Josephson","year":"2017","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.ebr.2025.100758_b0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: a bidirectional association","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ebr.2025.100758_b0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13311-014-0271-4","article-title":"Biomarkers of epileptogenesis: psychiatric comorbidities (?)","volume":"11","author":"Kanner","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ebr.2025.100758_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicenter study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.ebr.2025.100758_b0085","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ebr.2025.100758_b0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopsych.2006.12.031","article-title":"Six-month prospective life charting ofmoodsymptoms withlamotriginemonotherapy versus placebo in rapid cycling bipolar disorder","volume":"63","author":"Goldberg","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.ebr.2025.100758_b0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.yebeh.2012.06.005","article-title":"Validation of the Spanish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)","volume":"24","author":"Di Capua","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.ebr.2025.100758_b0100","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ebr.2025.100758_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108585","article-title":"Screening for epilepsy-specific anxiety symptoms: French validation of the EASI","volume":"128","author":"Micoulaud-Franchi","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.ebr.2025.100758_b0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.wnl.0000172917.70752.05","article-title":"Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders","volume":"65","author":"Ettinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2025.100758_b0115","unstructured":"Charney DS, Berman RM, Miller HL. Treatment of depression. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology, Second Edition. American Psychiatric Association Press; Washing- ton, DC, pp. 705\u2013732; 1998."},{"key":"10.1016\/j.ebr.2025.100758_b0120","series-title":"Psychiatrie","author":"Kraepelin","year":"1903"},{"key":"10.1016\/j.ebr.2025.100758_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0896-6974(88)80119-1","article-title":"Pharmacologic treatment of psychiatric disorders associated with epilepsy","volume":"1","author":"Blumer","year":"1988","journal-title":"J Epilepsy"},{"issue":"7","key":"10.1016\/j.ebr.2025.100758_b0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1528-1167.2009.02424.x","article-title":"Interictal dysphoric disorder and peri ictal dysphoric symptoms in patients with epilepsy","volume":"51","author":"Mula","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100758_b0135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/01.WNL.0000113763.11862.26","article-title":"Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy","volume":"62","author":"Kanner","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ebr.2025.100758_b0140","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2018.4561","article-title":"Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription","volume":"76","author":"Josephson","year":"2019","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.ebr.2025.100758_b0145","article-title":"Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel\u2026 and to placebo?","volume":"25","author":"Kanner","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2025.100758_b0150","first-page":"909","article-title":"Phenobarbital treatment and major depressive disorder in children with epilepsy","volume":"80","author":"Brent","year":"1987","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ebr.2025.100758_b0155","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1528-1167.2008.01799.x","article-title":"The role of titration schedule of topiramate for the development of depression in patients with epilepsy","volume":"50","author":"Mula","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100758_b0160","doi-asserted-by":"crossref","unstructured":"Kanner AM. Management of psychiatric and neurological comorbidities in epilepsy. Nature Reviews Neurol 2016 Feb;(12)2: 106-16.","DOI":"10.1038\/nrneurol.2015.243"},{"key":"10.1016\/j.ebr.2025.100758_b0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/epi.13373","article-title":"Validation of rapid suicidality screening in epilepsy using the NDDIE","volume":"57","author":"Mula","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100758_b0170","series-title":"The Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.ebr.2025.100758_b0175","unstructured":"U.S. Food and Drug Administration: Center for Drug Evaluation and Research. Information for healthcare professionals: suicidality and antiepileptic drugs [online]http:\/\/www.fda.gov\/cder\/drug\/InfoSheets\/HCP\/antiepilepticsHCP.htm."},{"issue":"5","key":"10.1016\/j.ebr.2025.100758_b0180","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","article-title":"The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100758_b0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: A bidirectional association","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebr.2025.100758_b0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.phrs.2016.03.022","article-title":"The pharmacological management of psychiatric comorbidities in patients with epilepsy","volume":"107","author":"Mula","year":"2016","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ebr.2025.100758_b0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ana.25561","article-title":"A trial of sertraline or cognitive behavior therapy for depression in epilepsy","volume":"86","author":"Gilliam","year":"2019","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ebr.2025.100758_b0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/070674371005500303","article-title":"The sequenced alternatives to relieve depression (STAR*D) trial: a review","volume":"55","author":"Sinyor","year":"2010","journal-title":"Can J Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.ebr.2025.100758_b0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yebeh.2017.02.032","article-title":"The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?","volume":"70","author":"Ribot","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.ebr.2025.100758_b0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/epi.17140","article-title":"ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy","volume":"63","author":"Mula","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100758_b0215","doi-asserted-by":"crossref","unstructured":"Kanner, AM. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Epilepsy & Behavior, Volume 61, 282 \u2013 286.","DOI":"10.1016\/j.yebeh.2016.03.022"},{"issue":"6","key":"10.1016\/j.ebr.2025.100758_b0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1017\/S1461145711001192","article-title":"Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme","volume":"15","author":"Letmaier","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.ebr.2025.100758_b0225","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.ebr.2025.100758_b0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ebr.2025.100758_b0235","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/epi.14444","article-title":"Psychological treatments for adults and children with epilepsy: evidence-based recommendations by the International League Against Epilepsy Psychology Task Force","volume":"59","author":"Michaelis","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ebr.2025.100758_b0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10865-010-9299-z","article-title":"A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being","volume":"34","author":"McLaughlin","year":"2011","journal-title":"J Behav Med"},{"issue":"Suppl 3","key":"10.1016\/j.ebr.2025.100758_b0245","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.yebeh.2003.08.019","article-title":"Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy","volume":"4","author":"Jones","year":"2003","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986425000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986425000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:11:23Z","timestamp":1748488283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986425000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"alternative-id":["S2589986425000188"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2025.100758","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major depression, anxiety disorder and suicidality in epilepsy: What should neurologists do?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2025.100758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100758"}}